Fully conversant AI driven bot to manage post-surgical care at home across multiple RPM devices.
Program 1.
Patient Enrolment
Program 2.
Device Installation
Program 3.
Real-time Engagement and Monitoring
Program 4.
Patient Discharge
and Feedbacks
No continuous Wi-Fi required
Easy integration with Medical Devices
Notebook screen to Pocket size
Interaction Level
Current Language
Emergency Handling
Management Programs
MiCure has a different set of
features for different regimes.
There are four types of regime care for the outpatient:
The solution has standard degrees identified for each type of regime care.
MiCure features the dynamic change in the prescription with alerts pushing prescription change
announcements.
Features:
Patient medication adherence is a critical part of the healthcare continuum. It plays a key role in patients quality and length of life and in the overall costs seen by patients and industry alike.
Fortunately, as with many other aspects of patient care, MiCure can be leveraged to be an effective tool in meeting this challenge. It has the feature of the regime over-medication tracking and medical parameters checks.
Patient engagement in the solution involves activities to encourage patients to make informed decisions about their own health.
Alice is provided with the capabilities to schedules many dierent activities such as - participating in surveys, following excercises, nominate one-self, share referrals code depending upon the therapy and checks the responses of the patient.
Social determinants of health (SDOH) are non-medical, economic and environmental conditions that both directly and indirectly impact one’s health, like access to transportation and nutritious food.
MiCure is taking care of environmental conditions in the current version of the solution. These parameters involve parameters like - environment study - temperature, humidity, oxygen, nitrogen, ozone level etc.
AI Powered Dashboard provides mathematical art and simulation capabilities such as predictive modelling and research theories integration.
Learn more about our productsThe solution in its test phase has attempted to create a digital twin of the heart in the live environment.
This feature is more in the realm of Research and Development currently- to explore all the possible benefits and to offer better preventive approaches with a faster and more accurate diagnosis. Solution is integrated with static feature of digital twin of the heart for normal heart-beat and sporty heart-beat.
Learn more about our productsThe product is designed to take RPM to its real definition that a program which can completely monitor the patient through out the regimen and keep them engage. Engagements can further results in adherence, satisfaction and treatment efficacy.
This will directly impact the entire stakeholder community from Patient, Provider, Payer, Caregiver, Medical Devices Company, Pharmaceuticals, Nutraceuticals, Diagnostics and State, Federal.
The product is getting registered under USPTO with provisional ID “M47563” and is funded by Govt. Authorities.
For complete product details request product brochure and for meeting click here: Calendar
The website does not collect any statistical and tracking data. Requests for information through the connect and careers ensures the protection of personal data by guaranteeing that data collection is carried out with the informed consent of individuals.
© 2021 CiRG Labs . All Rights Reserved. CiRG believes that the provided information in this website is accurate as of its publication date; such information is subject to change without notice. CiRG acknowledges the proprietary rights of other companies to the trademarks, product names and such other intellectual property rights mentioned in this document. Except as expressly permitted, neither this documentation nor any part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, printing, photocopying, recording or otherwise, without the prior permission of CiRG Labs and/ or any named intellectual property rights holders under this document.